Vol. 48 No. 4 (2009): Acta Oncologica

Articles

• Behind : In Response to Drs. Mavroidis and Lind

  Jian Z. Wang, Zhibin Huang, Nina A. Mayr, William T. C. Yuh

  614-617

  Published: 2009-01-01

  • PDF

• Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma

  Benjamin Y. S. Chuah, Wee-Lee Yeo, Jia Yi Guo, Seng-Gee Lim, Hui-Ling Yap, Boon-Cher Goh, Soo-Chin Lee

  628-630

  Published: 2009-01-01

  • PDF

• Malignant arrhythmia: A case report of nasal NK/T-cell lymphoma with cardiac involvement

  Ravindran Kanesvaran, Miriam Tao, Iain Tan Bee Huat, Daniel Tan Shao Weng, David Ng Chee Eng, Lim Soon Thye

  637-639

  Published: 2009-01-01

  • PDF

• Review of MammoSite brachytherapy: Advantages, disadvantages and clinical outcomes

  Saleh Bensaleh, Eva Bezak, Martin Borg

  487-494

  Published: 2009-01-01

  • PDF

• Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark

  Jeanne Debess, Jens Østergaard Riis, Lars Pedersen, Marianne Ewertz

  532-540

  Published: 2009-01-01

  • PDF

• Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy

  Umberto Ricardi, Andrea Riccardo Filippi, Alessia Guarneri, Francesca Romana Giglioli, Cristina Mantovani, Christian Fiandra, Silvia Anglesio, Riccardo Ragona

  571-577

  Published: 2009-01-01

  • PDF

• Rare skin cancer: A population-based cancer registry descriptive study of 151 consecutive cases diagnosed between 1980 and 2004.

  Marie-Odile Riou-Gotta, Evelyne Fournier, Arlette Danzon, Fabien Pelletier, Julien Levang, Isabelle Mermet, Dominique Blanc, Philippe Humbert, François Aubin

  605-609

  Published: 2009-01-01

  • PDF

• Flare-up: An often unreported phenomenon nevertheless familiar to oncologists prescribing tyrosine kinase inhibitors

  Pascal Wolter, Benoit Beuselinck, Steven Pans, Patrick Schöffski

  621-624

  Published: 2009-01-01

  • PDF

• Mangafodipir as a cytoprotective adjunct to chemotherapy – a case report

  Olav Erich Yri, Jens Vig, Elisabeth Hegstad, Øistein Hovde, Ingrid Pignon, Per Jynge

  633-635

  Published: 2009-01-01

  • PDF

• Co-expression of estrogen receptor α and Apolipoprotein D in node positive operable breast cancer – possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

  Håvard Søiland, Ivar Skaland, Jan Erik Varhaug, Hartwig Kørner, Emiel A.M. Janssen, Einar Gudlaugsson, Jan P.A. Baak, Jon Arne Søreide

  514-521

  Published: 2009-01-01

  • PDF

• Half body irradiation of patients with multiple bone metastases: A phase II trial

  Randi S. Berg, Mette K. Yilmaz, Morten Høyer, Nina Keldsen, Ole S. Nielsen, Marianne Ewertz

  556-561

  Published: 2009-01-01

  • PDF

• Quantitative analysis of tumor growth rate and changes in tumor marker level: Specific growth rate versus doubling time

  Esmaeil Mehrara, Eva Forssell-Aronsson, Håkan Ahlman, Peter Bernhardt

  591-597

  Published: 2009-01-01

  • PDF

• Analyzing Toposimerase II-α and HER-2/neu co-amplification seems to be of limited value in epithelial ovarian cancer

  Johanna Mäenpää, Minna Tanner, Jorma Isola

  617-619

  Published: 2009-01-01

  • PDF

• Evolution of glioblastoma

  Silvia Hofer, Spyros Kollias, Michael Weller

  630-631

  Published: 2009-01-01

  • PDF

• A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and Volumetric modulated arc treatment techniqu

  Safora Johansen, Luca Cozzi, Dag Rune Olsen

  495-503

  Published: 2009-01-01

  • PDF

• Squamous cell carcinoma of the hypopharynx: Single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches

  Tejpal Gupta, Supriya Chopra, Jai Prakash Agarwal, Sarbani-Ghosh Laskar, Anil K. D’cruz, Shyam K. Shrivastava, Ketayun A. Dinshaw

  541-548

  Published: 2009-01-01

  • PDF

• Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis

  Kyle E. Rusthoven, Susan F. Hammerman, Brian D. Kavanagh, Michael J. Birtwhistle, Mark Stares, D. Ross Camidge

  578-583

  Published: 2009-01-01

  • PDF

• In response to ‘Behind EUD’

  Panayiotis Mavroidis, Bengt K. Lind

  610-614

  Published: 2009-01-01

  • PDF

• A suspicion of chikungunya leading to a diagnosis of angioimmunoblastic T-cell lymphoma

  Fadi Braiteh, Ankur Parikh, Peter McLaughlin

  624-628

  Published: 2009-01-01

  • PDF

• An unusual presentation of hand-foot syndrome at the hidden area: The scrotum and penis

  Young Joo Lee, Hee Jung Lee, Ki Cheon Jeong, Jung Gu Kang, Sang Hoon Lee, Yong Tai Kim

  636-637

  Published: 2009-01-01

  • PDF

• Accelerated partial breast cancer irradiation (APBI)–the future breast cancer radiotherapy?

  Per Karlsson

  485-486

  Published: 2009-01-01

  • PDF

• An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer

  Katrine L. Henriksen, Birgitte B. Rasmussen, Anne E. Lykkesfeldt, Susanne Møller, Bent Ejlertsen, Henning T. Mouridsen

  522-531

  Published: 2009-01-01

  • PDF

• Hypofractionated radiotherapy denoted as the “Christie scheme”: An effective means of palliating patients with head and neck cancers not suitable for curative treatment

  Abrahim Al-mamgani, Lisa Tans, Peter H. E. Van rooij, Inge Noever, Robert J. Baatenburg de jong, Peter C. Levendag

  562-570

  Published: 2009-01-01

  • PDF

• Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: Clinical, histological and immunohistochemical features of 52 cases

  Achiléa L. Bittencourt, Helenemarie S. Barbosa, Maria Das Graças Vieira, Lourdes Farré

  598-604

  Published: 2009-01-01

  • PDF

• Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma

  Arun Azad, Rebecca A. Herbertson, David Pook, Shane White, Paul L. R. Mitchell, Niall C. Tebbutt

  619-621

  Published: 2009-01-01

  • PDF

• Fatal drug-drug interaction of brivudine and capecitabine

  Alexandra E. Rätz Bravo, Silvia Hofer, Stephan Krähenbühl, Christian Ludwig

  631-633

  Published: 2009-01-01

  • PDF

• Improved survival for women with stage I breast cancer in south-east Sweden: A comparison between two time periods before and after increased use of adjuvant systemic therapy

  Patrik Johansson, Helena Fohlin, Lars-Gunnar Arnesson, Monika Dufmats, Kerstin Nordenskjöld, Bo Nordenskjöld, Olle Stål, Måns Agrup, Lars-Gunnar Arnesson, Bengt Asking, Tord Blomkvist, Harald Bång, Charlotta Dabrosin, Monika Dufmats, Eibert Einarsson, Helena Fohlin, Rune Gustavsson, Claes Klintenberg, Barbro Linderholm, Annika Malmström, Rebecka Malterling, Marie Sundquist, Bengt Norberg, Ann Rundcrantz, Peter Skoog, Hans Starkhammar, Marie Stenmark Askmalm, Göran Tejler, Sten Thorstenson, Susanne Vahlin, Bedrich Vitak

  504-513

  Published: 2009-01-01

  • PDF

• Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival

  Lena Cederblad, Silvia Johansson, Gunilla Enblad, Mats Engström, Erik Blomquist

  549-555

  Published: 2009-01-01

  • PDF

• Comparison of predicted and clinical response to radiotherapy: A radiobiology modelling study

  Mattias Hedman, Thomas Björk-Eriksson, Claes Mercke, Catharine West, Patrick Hesselius, Ola Brodin

  584-590

  Published: 2009-01-01

  • PDF